Tag Archives: als

Breakthrough in ALS Treatment: FP802 Inhibitor Shows Promise – Medriva

Posted: Published on February 12th, 2024

A Breakthrough in ALS Treatment Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by rapid, progressive loss of motor neurons in the brain and spinal cord. This debilitating condition, for which there is currently no cure, may soon see a ray of hope with the discovery of a new pharmacological inhibitor, FP802. Recent research funded by the German Research Foundation, the European Research Council, and the Alexander von Humboldt Foundation has unveiled the potential of this inhibitor in the treatment of ALS. Continue reading

Posted in ALS Treatment | Comments Off on Breakthrough in ALS Treatment: FP802 Inhibitor Shows Promise – Medriva

New drug targets key mechanism in ALS, protects motor neurons – News-Medical.Net

Posted: Published on February 12th, 2024

A new pharmacological inhibitor can intervene in a central cell death mechanism that is responsible for the death of motor neurons and hence important for the progression of the motor neuron disease amyotrophic lateral sclerosis (ALS). A research team led by Prof Continue reading

Posted in ALS Treatment | Comments Off on New drug targets key mechanism in ALS, protects motor neurons – News-Medical.Net

Heidelberg University’s Groundbreaking Discovery in ALS Treatment – Medriva

Posted: Published on February 12th, 2024

Groundbreaking Discovery by Heidelberg University In a major advancement towards the treatment of amyotrophic lateral sclerosis (ALS), a research team led by Prof. Dr. Continue reading

Posted in ALS Treatment | Comments Off on Heidelberg University’s Groundbreaking Discovery in ALS Treatment – Medriva

Revolutionary Discovery: FP802 Inhibitor Offers Hope for ALS Patients – Medriva

Posted: Published on February 12th, 2024

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrigs disease, is a progressive neurodegenerative condition marked by the loss of motor neurons, cells that control voluntary muscles. This fatal disease has been a longstanding challenge for researchers and physicians, with no effective cure available Continue reading

Posted in ALS Treatment | Comments Off on Revolutionary Discovery: FP802 Inhibitor Offers Hope for ALS Patients – Medriva

New Treatment Strategy Offers Hope for Halting ALS Progression – Northeastern University

Posted: Published on February 4th, 2024

A major breakthrough in the treatment of amyotrophic lateral sclerosis, known as ALS, can potentially help stop the disease in its tracks in as much as half of the cases in the U.S., a Northeastern University scientist says. Jeffrey Agar, associate professor of chemistry and pharmaceutical sciences at Northeastern, has spent the last 12 years studying the mechanism of ALS and researching ways to prevent its progression. Continue reading

Posted in ALS Treatment | Comments Off on New Treatment Strategy Offers Hope for Halting ALS Progression – Northeastern University

Aaron Lazar Says He Won’t ‘Fight’ ALS After His Diagnosis: ‘There’s Nothing to Beat’ – PEOPLE

Posted: Published on February 4th, 2024

Aaron Lazar is opening up about his diagnosis with amyotrophic lateral sclerosis (ALS), and revealing why he's not focused on trying to fight the disease for which there is no cure, but instead move through life with courage and hope. The stage veteran known for two decades of roles on Broadway and on tour in musicals like The Light in the Piazza, Dear Evan Hansen, Les Misrables, A Little Night Music and The Last Ship went public in January with the news that he had the progressive neurogenerative disorder, after being diagnosed two years ago. During a candid interview on The Broadway Show with Tamsen Fadal, the 47-year-old actor and singer explained he's since been on a healing journey" focused on taking care of his mind, body and spirit. Continue reading

Posted in ALS Treatment | Comments Off on Aaron Lazar Says He Won’t ‘Fight’ ALS After His Diagnosis: ‘There’s Nothing to Beat’ – PEOPLE

Phase 3 clinical trial of pridopidine in ALS patients likely this year – ALS News Today

Posted: Published on February 4th, 2024

On the heels of promising HEALEY-ALS Phase 2 trial data, Prilenia Therapeutics plans to launch a pivotal Phase 3 study of pridopidine, its candidate amyotrophic lateral sclerosis (ALS) treatment, in the second half of this year. Relative to a placebo, pridopidine was associated with slower disease progression, a better life quality, and a potential to prolong survival in patients in early disease stages. These recently diagnosed ALS patients with rapidly progressing symptoms saw particular benefit in terms of respiratory health and speech, although better speech was evident across all treated patients Continue reading

Posted in ALS Treatment | Comments Off on Phase 3 clinical trial of pridopidine in ALS patients likely this year – ALS News Today